Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy M Anderson

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Life Sciences|April 17, 2003
Susceptibility to postnatal growth retardation induced by 5-AZA-2'-deoxycytidine in utero: gender specificity and correlation with reduced insulin-like growth factor 1Francisco Javier Cisneros, Ralph Wilson, Gregory Travlos, et al.
Mutation Research|November 16, 2004
Intra- and intercellular variations in the repair efficiency of O6-methylguanine, and their contribution to kinetic complexityVassilis L Souliotis, Petros P Sfikakis, Lucy M Anderson, et al.
Biochemical Pharmacology|September 29, 2006
Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strainRichard J Calvert, Shirley Tepper, Wafa Kammouni, et al.
Journal of Biomedical Optics|November 8, 2002
Robustness of the Chen-Dougherty-Bittner procedure against non-normality and heterogeneity in the coefficient of variationDouglas A Powell, Lucy M Anderson, Robert Y S Cheng, et al.
Toxicology and Applied Pharmacology|June 1, 2005
Allele-specific germ cell epimutation in the spacer promoter of the 45S ribosomal RNA gene after Cr(III) exposureYih-Horng Shiao, Erik B Crawford, Lucy M Anderson, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2013
K-ras 4A and 4B mRNA levels correlate with superoxide in lung adenocarcinoma cells, while at the protein level, only mutant K-ras 4A protein correlates with superoxideRichard J Calvert, Meghana Gupta, Anna Maciag, et al.
Biochemical Pharmacology|August 9, 2003
Treatment with lovastatin, cholestyramine or niacin alters K-ras membrane association in mouse lung in a strain-dependent manner: results in femalesRichard J Calvert, Shirley Tepper, Bhalchandra A Diwan, et al.
International Journal of Cancer|March 10, 2011
Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenograftsGunamani Sithanandam, Laura W Fornwald, Janet R Fields, et al.
Kidney International|October 9, 2003
VHL down-regulation and differential localization as mechanisms in tumorigenesisYih-Horng Shiao, Asta Forsti, Lars Egevad, et al.
American Journal of Respiratory Cell and Molecular Biology|August 2, 2005
Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1Gunamani Sithanandam, George T Smith, Janet R Fields, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Life Sciences|April 17, 2003
Susceptibility to postnatal growth retardation induced by 5-AZA-2'-deoxycytidine in utero: gender specificity and correlation with reduced insulin-like growth factor 1Francisco Javier Cisneros, Ralph Wilson, Gregory Travlos, et al.
Mutation Research|November 16, 2004
Intra- and intercellular variations in the repair efficiency of O6-methylguanine, and their contribution to kinetic complexityVassilis L Souliotis, Petros P Sfikakis, Lucy M Anderson, et al.
Biochemical Pharmacology|September 29, 2006
Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strainRichard J Calvert, Shirley Tepper, Wafa Kammouni, et al.
Journal of Biomedical Optics|November 8, 2002
Robustness of the Chen-Dougherty-Bittner procedure against non-normality and heterogeneity in the coefficient of variationDouglas A Powell, Lucy M Anderson, Robert Y S Cheng, et al.
Toxicology and Applied Pharmacology|June 1, 2005
Allele-specific germ cell epimutation in the spacer promoter of the 45S ribosomal RNA gene after Cr(III) exposureYih-Horng Shiao, Erik B Crawford, Lucy M Anderson, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2013
K-ras 4A and 4B mRNA levels correlate with superoxide in lung adenocarcinoma cells, while at the protein level, only mutant K-ras 4A protein correlates with superoxideRichard J Calvert, Meghana Gupta, Anna Maciag, et al.
Biochemical Pharmacology|August 9, 2003
Treatment with lovastatin, cholestyramine or niacin alters K-ras membrane association in mouse lung in a strain-dependent manner: results in femalesRichard J Calvert, Shirley Tepper, Bhalchandra A Diwan, et al.
International Journal of Cancer|March 10, 2011
Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenograftsGunamani Sithanandam, Laura W Fornwald, Janet R Fields, et al.
Kidney International|October 9, 2003
VHL down-regulation and differential localization as mechanisms in tumorigenesisYih-Horng Shiao, Asta Forsti, Lars Egevad, et al.
American Journal of Respiratory Cell and Molecular Biology|August 2, 2005
Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1Gunamani Sithanandam, George T Smith, Janet R Fields, et al.
Pageof 5